As of May 2024 Sonoma Pharmaceuticals has a market cap of $2.38 Million. This makes Sonoma Pharmaceuticals the world's 8312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.38 M | -3.17% |
2023 | $2.46 M | -29.06% |
2022 | $3.47 M | -75.39% |
2021 | $14.13 M | -6.37% |
2020 | $15.09 M | 94.77% |
2019 | $7.74 M | -9.15% |
2018 | $8.53 M | -64.46% |
2017 | $24 M | 13.05% |
2016 | $21.23 M | 6.45% |
2015 | $19.94 M | 61.03% |
2014 | $12.38 M | -50.84% |
2013 | $25.19 M | 10.6% |
2012 | $22.77 M | -19.36% |
2011 | $28.24 M | -36.84% |
2010 | $44.72 M | -1.86% |
2009 | $45.57 M | 178.95% |
2008 | $16.33 M | -65.12% |
2007 | $46.83 M |
On May 2nd, 2024 the market cap of Sonoma Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.90 B | 37,819.74% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | 774.86% | ๐บ๐ธ USA |